Literature DB >> 22612200

Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes.

Erik G Willcutt1, Joel T Nigg, Bruce F Pennington, Mary V Solanto, Luis A Rohde, Rosemary Tannock, Sandra K Loo, Caryn L Carlson, Keith McBurnett, Benjamin B Lahey.   

Abstract

Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for attention deficit/hyperactivity disorder (ADHD) specify two dimensions of inattention and hyperactivity-impulsivity symptoms that are used to define three nominal subtypes: predominantly hyperactive-impulsive type (ADHD-H), predominantly inattentive type (ADHD-I), and combined type (ADHD-C). To aid decision making for DSM-5 and other future diagnostic systems, a comprehensive literature review and meta-analysis of 546 studies was completed to evaluate the validity of the DSM-IV model of ADHD. Results indicated that DSM-IV criteria identify individuals with significant and persistent impairment in social, academic, occupational, and adaptive functioning when intelligence, demographic factors, and concurrent psychopathology are controlled. Available data overwhelmingly support the concurrent, predictive, and discriminant validity of the distinction between inattention and hyperactivity-impulsivity symptoms, and indicate that nearly all differences among the nominal subtypes are consistent with the relative levels of inattention and hyperactivity-impulsivity symptoms that define the subtypes. In contrast, the DSM-IV subtype model is compromised by weak evidence for the validity of ADHD-H after first grade, minimal support for the distinction between ADHD-I and ADHD-C in studies of etiological influences, academic and cognitive functioning, and treatment response, and the marked longitudinal instability of all three subtypes. Overall, we conclude that the DSM-IV ADHD subtypes provide a convenient clinical shorthand to describe the functional and behavioral correlates of current levels of inattention and hyperactivity-impulsivity symptoms, but do not identify discrete subgroups with sufficient long-term stability to justify the classification of distinct forms of the disorder. Empirical support is stronger for an alternative model that would replace the subtypes with dimensional modifiers that reflect the number of inattention and hyperactivity-impulsivity symptoms at the time of assessment. (PsycINFO Database Record (c) 2012 APA, all rights reserved).

Entities:  

Mesh:

Year:  2012        PMID: 22612200      PMCID: PMC3622557          DOI: 10.1037/a0027347

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  64 in total

1.  Predictive validity of a continuous alternative to nominal subtypes of attention-deficit/hyperactivity disorder for DSM-V.

Authors:  Benjamin B Lahey; Erik G Willcutt
Journal:  J Clin Child Adolesc Psychol       Date:  2010

2.  Family psychiatric history evidence on the nosological relations of DSM-IV ADHD combined and inattentive subtypes: new data and meta-analysis.

Authors:  Julie Ann Stawicki; Joel T Nigg; Alexander von Eye
Journal:  J Child Psychol Psychiatry       Date:  2006-09       Impact factor: 8.982

3.  A multitrait-multisource confirmatory factor analytic approach to the construct validity of ADHD and ODD rating scales with Malaysian children.

Authors:  Rapson Gomez; G Leonard Burns; James A Walsh; Nina Hafetz
Journal:  J Abnorm Child Psychol       Date:  2005-04

4.  Familiality and heritability of subtypes of attention deficit hyperactivity disorder in a population sample of adolescent female twins.

Authors:  R D Todd; E R Rasmussen; R J Neuman; W Reich; J J Hudziak; K K Bucholz; P A Madden; A Heath
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

5.  Statistical analyses of structural magnetic resonance imaging of the head of the caudate nucleus in Colombian children with attention-deficit hyperactivity disorder.

Authors:  David A Pineda; M Adelaida Restrepo; Ruth J Sarmiento; Juan E Gutierrez; Sergio A Vargas; Yakel T Quiroz; George W Hynd
Journal:  J Child Neurol       Date:  2002-02       Impact factor: 1.987

6.  Differences between attention-deficit disorder with and without hyperactivity: a 1H-magnetic resonance spectroscopy study.

Authors:  Li Sun; Zhen Jin; Yu-feng Zang; Ya-Wei Zeng; Gang Liu; Yang Li; Larry J Seidman; Stephen V Faraone; Yu-feng Wang
Journal:  Brain Dev       Date:  2005-08       Impact factor: 1.961

7.  Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age.

Authors:  Benjamin B Lahey; William E Pelham; Jan Loney; Heidi Kipp; Ashley Ehrhardt; Steve S Lee; Erik G Willcutt; Cynthia M Hartung; Andrea Chronis; Greta Massetti
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

8.  Social skills training in children with attention deficit hyperactivity disorder: a randomized-controlled clinical trial.

Authors:  Kevin M Antshel; Rory Remer
Journal:  J Clin Child Adolesc Psychol       Date:  2003-03

9.  Use of medication by young people with attention-deficit/hyperactivity disorder.

Authors:  Michael G Sawyer; Joseph M Rey; Brian W Graetz; Jennifer J Clark; Peter A Baghurst
Journal:  Med J Aust       Date:  2002-07-01       Impact factor: 7.738

10.  DSM-IV field trials for the disruptive behavior disorders: symptom utility estimates.

Authors:  P J Frick; B B Lahey; B Applegate; L Kerdyck; T Ollendick; G W Hynd; B Garfinkel; L Greenhill; J Biederman; R A Barkley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994-05       Impact factor: 8.829

View more
  273 in total

1.  Future directions in ADHD etiology research.

Authors:  Joel T Nigg
Journal:  J Clin Child Adolesc Psychol       Date:  2012-05-29

2.  A network analysis of developmental change in ADHD symptom structure from preschool to adulthood.

Authors:  Michelle M Martel; Cheri A Levinson; Julia K Langer; Joel T Nigg
Journal:  Clin Psychol Sci       Date:  2016-03-04

3.  Assessing sluggish cognitive tempo and ADHD inattention in elementary students: Empirical differentiation, invariance across sex and grade, and measurement precision.

Authors:  Stephen P Becker; Kandace W Mossing; Allison K Zoromski; Aaron J Vaughn; Jeffery N Epstein; Leanne Tamm; G Leonard Burns
Journal:  Psychol Assess       Date:  2020-07-30

4.  Genetic influences on ADHD symptom dimensions: Examination of a priori candidates, gene-based tests, genome-wide variation, and SNP heritability.

Authors:  L Cinnamon Bidwell; Joshua C Gray; Jessica Weafer; Abraham A Palmer; Harriet de Wit; James MacKillop
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-06       Impact factor: 3.568

Review 5.  Aberrant Modulation of Brain Oscillatory Activity and Attentional Impairment in Attention-Deficit/Hyperactivity Disorder.

Authors:  Agatha Lenartowicz; Ali Mazaheri; Ole Jensen; Sandra K Loo
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-10-06

6.  Validity of the sluggish cognitive tempo symptom dimension in children: sluggish cognitive tempo and ADHD-inattention as distinct symptom dimensions.

Authors:  SoYean Lee; G Leonard Burns; Jerry Snell; Keith McBurnett
Journal:  J Abnorm Child Psychol       Date:  2014-01

7.  Are There Executive Dysfunction Subtypes Within ADHD?

Authors:  Bethan A Roberts; Michelle M Martel; Joel T Nigg
Journal:  J Atten Disord       Date:  2016-07-28       Impact factor: 3.256

Review 8.  Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research.

Authors:  Brooke S G Molina; William E Pelham
Journal:  Annu Rev Clin Psychol       Date:  2014-01-15       Impact factor: 18.561

9.  The relationship between ADHD symptom dimensions, clinical correlates, and functional impairments.

Authors:  Annie A Garner; Briannon C Oʼconnor; Megan E Narad; Leanne Tamm; John Simon; Jeffery N Epstein
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

10.  Parental Cognitive Errors Mediate Parental Psychopathology and Ratings of Child Inattention.

Authors:  Lauren M Haack; Yuan Jiang; Kevin Delucchi; Nina Kaiser; Keith McBurnett; Stephen Hinshaw; Linda Pfiffner
Journal:  Fam Process       Date:  2016-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.